| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Departments of Pathology and Laboratory Medicine,* Urology, and Medicine,|| Indiana University, Indianapolis, Indiana; the Department of Pathology, Cordoba University, Cordoba, Spain; the Department of Pathology,¶ Northwestern University, Chicago, Illinois; and the Department of Pathology, Case Western Reserve University, Cleveland, Ohio
In most cases, small-cell carcinoma of the urinary bladder is admixed with other histological types of bladder carcinoma. To understand the pathogenetic relationship between the two tumor types, we analyzed histologically distinct tumor cell populations from the same patient for loss of heterozygosity (LOH) and X chromosome inactivation (in female patients). We examined five polymorphic microsatellite markers located on chromosome 3p25-26 (D3S3050), chromosome 9p21 (IFNA and D9S171), chromosome 9q32-33 (D9S177), and chromosome 17p13 (TP53) in 20 patients with small-cell carcinoma of the urinary bladder and concurrent urothelial carcinoma. DNA samples were prepared from formalin-fixed, paraffin-embedded tissue sections using laser-assisted microdissection. A nearly identical pattern of allelic loss was observed in the two tumor types in all cases, with an overall frequency of allelic loss of 90% (18 of 20 cases). Three patients showed different allelic loss patterns in the two tumor types at a single locus; however, the LOH patterns at the remaining loci were identical. Similarly, the same pattern of nonrandom X chromosome inactivation was present in both carcinoma components in the four cases analyzed. Concordant genetic alterations and X chromosome inactivation between small-cell carcinoma and coexisting urothelial carcinoma suggest that both tumor components originate from the same cells in the urothelium.
This article has been cited by other articles:
 |
|
 |
|
  M.-T. Sung, S. Zhang, G. T. MacLennan, A. Lopez-Beltran, R. Montironi, M. Wang, P.-H. Tan, and L. Cheng Histogenesis of Clear Cell Adenocarcinoma in the Urinary Tract: Evidence of Urothelial Origin Clin. Cancer Res., April 1, 2008; 14(7): 1947 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Jones, M. Wang, M.-T. Sung, S. Zhang, T. M. Ulbright, J. N. Eble, S. D. Beck, R. S. Foster, J. J. Anagnostou Jr., C. Conner, et al. Clonal Origin of Metastatic Testicular Teratomas Clin. Cancer Res., September 15, 2006; 12(18): 5377 - 5383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Katona, T. D. Jones, M. Wang, F. W. Abdul-Karim, O. W. Cummings, and L. Cheng Molecular Evidence for Independent Origin of Multifocal Neuroendocrine Tumors of the Enteropancreatic Axis. Cancer Res., May 1, 2006; 66(9): 4936 - 4942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. McCarthy, M. Wang, T. D. Jones, R. W. Strate, and L. Cheng Molecular Evidence for the Same Clonal Origin of Multifocal Papillary Thyroid Carcinomas Clin. Cancer Res., April 15, 2006; 12(8): 2414 - 2418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Jones, J. N. Eble, M. Wang, G. T. MacLennan, B. Delahunt, M. Brunelli, G. Martignoni, A. Lopez-Beltran, S. M. Bonsib, T. M. Ulbright, et al. Molecular Genetic Evidence for the Independent Origin of Multifocal Papillary Tumors in Patients with Papillary Renal Cell Carcinomas Clin. Cancer Res., October 15, 2005; 11(20): 7226 - 7233. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
